EAGLE CRAIG, an insider at Guardant Health Inc (GH), sold 45,007 shares of company stock on December 14, 2025, at a price of $102.67 per share. The total transaction value reached $4.62 million. Following this sale, CRAIG retains 45,007 shares of the company.
Guardant Health, headquartered in Palo Alto, California, is a precision oncology company specializing in cancer treatment through proprietary blood-based tests and advanced analytics. The company has a market capitalization of $12.1 billion and reported an EPS of -3.21 for the trailing twelve months.
Insider transactions, such as this sale, are reported to the SEC and provide transparency into executives' views on their company's stock. While a single insider's selling activity may raise questions, it is essential for investors to consider broader patterns across multiple insiders and time periods when evaluating these signals.
Guardant Health is set to announce its upcoming earnings on July 28, 2026, with an EPS estimate of -0.61 and revenue expectation of $305.5 million.